SGL Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
3,193
-22
-0.7% -$7.53K 0.46% 48
2026
Q1
$1.06M Sell
3,215
-25
-0.8% -$8.91K 0.4% 56
2025
Q4
$1.19M Buy
3,240
+39
+1% +$12.4K 0.48% 47
2025
Q3
$948K Buy
3,201
+1,101
+52% +$319K 0.4% 48
2025
Q2
$624K Buy
2,100
+29
+1% +$8.22K 0.3% 67
2025
Q1
$563K Sell
2,071
-62
-3% -$18.3K 0.29% 67
2024
Q4
$629K Sell
2,133
-535
-20% -$159K 0.32% 63
2024
Q3
$790K Buy
+2,668
New +$873K 0.41% 48

Other funds holding AMGN

SGL Investment Advisors's AMGN Position: Q2 2026 in Review

SGL Investment Advisors reduced its Amgen (AMGN) stake by 0.68% in Q2 2026, selling an estimated $7.53K and leaving 3,193 shares worth $1.33M. The position accounts for 0.46% of the portfolio, ranked #48.

SGL Investment Advisors first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SGL Investment Advisors held 3,193 shares of Amgen worth $1.33M as of Q2 2026.
  • SGL Investment Advisors sold 22 Amgen shares in Q2 2026, an estimated $7.53K.
  • Amgen made up 0.46% of SGL Investment Advisors's portfolio in Q2 2026, its #48 holding.
  • SGL Investment Advisors first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.